Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1, updates to tumour pathology and cancer incidences
Andrew Lee, Nasim Mavaddat, Alex P. Cunningham, Tim Carver, Stephanie Archer, Fiona M. Walter, Marc Tischkowitz, Jonathan Roberts, Juliet Usher-Smith, Jacques Simard, Marjanka K. Schmidt, Peter Devilee, Vesna Zadnik, Hannes Jürgens, Emmanuelle Mouret-Fourme, Antoine De Pauw, Matti Rookus, Thea M. Mooij, Paul P.D. Pharoah, Douglas F. Easton, View ORCID ProfileAntonis C. Antoniou
doi: https://doi.org/10.1101/2022.01.27.22269825
Andrew Lee
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
Nasim Mavaddat
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
Alex P. Cunningham
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
Tim Carver
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
Stephanie Archer
2The Primary Care Unit, Department of Public Health & Primary Care, The University of Cambridge, Cambridge, CB1 8RN, UK
Fiona M. Walter
2The Primary Care Unit, Department of Public Health & Primary Care, The University of Cambridge, Cambridge, CB1 8RN, UK
3Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK
Marc Tischkowitz
4Department of Medical Genetics and National Institute for Health Research, Cambridge Biomedical Research Centre, The University of Cambridge, Cambridge, UK
Jonathan Roberts
4Department of Medical Genetics and National Institute for Health Research, Cambridge Biomedical Research Centre, The University of Cambridge, Cambridge, UK
Juliet Usher-Smith
2The Primary Care Unit, Department of Public Health & Primary Care, The University of Cambridge, Cambridge, CB1 8RN, UK
Jacques Simard
5Centre Hospitalier Universitaire de Québec–Université Laval Research Center, 2705 Laurier Boulevard, Québec City, QC, G1V4G2, Canada
Marjanka K. Schmidt
6Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
Peter Devilee
7Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
Vesna Zadnik
8Epidemiology and Cancer Registry, Institute of Oncology, Ljubljana, Slovenia
Hannes Jürgens
9Tartu University Hospital, Clinic of Hematology & Oncology, Puusepa 8, Tartu, Estonia
Emmanuelle Mouret-Fourme
10Service de Génétique, Institut Curie, 35, rue Dailly, Saint-Cloud, 92210, France
Antoine De Pauw
11Service de Génétique, Institut Curie, 26, rue d’Ulm, Paris, 75005, France
Matti Rookus
12Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands
Thea M. Mooij
12Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands
Paul P.D. Pharoah
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
13Centre for Cancer Genetic Epidemiology, Department of Oncology, The University of Cambridge, Cambridge CB1 8RN, UK
Douglas F. Easton
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
13Centre for Cancer Genetic Epidemiology, Department of Oncology, The University of Cambridge, Cambridge CB1 8RN, UK
Antonis C. Antoniou
1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
Data Availability
No individual level data used. The algorithm development was performed using publicly available parameter estimates. The algorithms developed are freely available for use via www.canrisk.org
Posted January 28, 2022.
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1, updates to tumour pathology and cancer incidences
Andrew Lee, Nasim Mavaddat, Alex P. Cunningham, Tim Carver, Stephanie Archer, Fiona M. Walter, Marc Tischkowitz, Jonathan Roberts, Juliet Usher-Smith, Jacques Simard, Marjanka K. Schmidt, Peter Devilee, Vesna Zadnik, Hannes Jürgens, Emmanuelle Mouret-Fourme, Antoine De Pauw, Matti Rookus, Thea M. Mooij, Paul P.D. Pharoah, Douglas F. Easton, Antonis C. Antoniou
medRxiv 2022.01.27.22269825; doi: https://doi.org/10.1101/2022.01.27.22269825
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1, updates to tumour pathology and cancer incidences
Andrew Lee, Nasim Mavaddat, Alex P. Cunningham, Tim Carver, Stephanie Archer, Fiona M. Walter, Marc Tischkowitz, Jonathan Roberts, Juliet Usher-Smith, Jacques Simard, Marjanka K. Schmidt, Peter Devilee, Vesna Zadnik, Hannes Jürgens, Emmanuelle Mouret-Fourme, Antoine De Pauw, Matti Rookus, Thea M. Mooij, Paul P.D. Pharoah, Douglas F. Easton, Antonis C. Antoniou
medRxiv 2022.01.27.22269825; doi: https://doi.org/10.1101/2022.01.27.22269825
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (425)
- Epidemiology (12511)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4380)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2825)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (892)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4144)
- Nursing (219)
- Nutrition (614)
- Oncology (2183)
- Ophthalmology (620)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (262)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6729)
- Radiology and Imaging (1479)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)